CN1778905A - 一种脂肪间充质干细胞的分离培养方法及其应用 - Google Patents
一种脂肪间充质干细胞的分离培养方法及其应用 Download PDFInfo
- Publication number
- CN1778905A CN1778905A CNA2004100844073A CN200410084407A CN1778905A CN 1778905 A CN1778905 A CN 1778905A CN A2004100844073 A CNA2004100844073 A CN A2004100844073A CN 200410084407 A CN200410084407 A CN 200410084407A CN 1778905 A CN1778905 A CN 1778905A
- Authority
- CN
- China
- Prior art keywords
- cell
- stem cell
- mesenchymal stem
- fat mesenchymal
- divided
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims abstract description 79
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 15
- 238000000338 in vitro Methods 0.000 claims abstract description 9
- 102100032912 CD44 antigen Human genes 0.000 claims abstract description 6
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims abstract description 6
- 238000005119 centrifugation Methods 0.000 claims abstract description 5
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 36
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 27
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 27
- 210000002919 epithelial cell Anatomy 0.000 claims description 16
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 13
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 230000003321 amplification Effects 0.000 claims description 10
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 10
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 10
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 claims description 9
- 210000003556 vascular endothelial cell Anatomy 0.000 claims description 8
- 210000001612 chondrocyte Anatomy 0.000 claims description 6
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 claims description 5
- 102100024210 CD166 antigen Human genes 0.000 claims description 4
- 102000029816 Collagenase Human genes 0.000 claims description 4
- 108060005980 Collagenase Proteins 0.000 claims description 4
- 102100037241 Endoglin Human genes 0.000 claims description 4
- 102000006354 HLA-DR Antigens Human genes 0.000 claims description 4
- 108010058597 HLA-DR Antigens Proteins 0.000 claims description 4
- 101000980840 Homo sapiens CD166 antigen Proteins 0.000 claims description 4
- 101000881679 Homo sapiens Endoglin Proteins 0.000 claims description 4
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims description 4
- 102100025304 Integrin beta-1 Human genes 0.000 claims description 4
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims description 4
- 210000000577 adipose tissue Anatomy 0.000 claims description 4
- 229960002424 collagenase Drugs 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 230000017423 tissue regeneration Effects 0.000 claims description 3
- 230000001582 osteoblastic effect Effects 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 abstract description 42
- 102000004190 Enzymes Human genes 0.000 abstract description 3
- 108090000790 Enzymes Proteins 0.000 abstract description 3
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 238000012136 culture method Methods 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 44
- 238000004043 dyeing Methods 0.000 description 17
- 238000003757 reverse transcription PCR Methods 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 16
- 108010088751 Albumins Proteins 0.000 description 15
- 102000009027 Albumins Human genes 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- 108010047303 von Willebrand Factor Proteins 0.000 description 12
- 238000011579 SCID mouse model Methods 0.000 description 11
- 230000004069 differentiation Effects 0.000 description 11
- 230000001413 cellular effect Effects 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 238000010166 immunofluorescence Methods 0.000 description 9
- 230000001939 inductive effect Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 8
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 108010043741 Collagen Type VI Proteins 0.000 description 7
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 7
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 7
- 210000003038 endothelium Anatomy 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 102000002734 Collagen Type VI Human genes 0.000 description 6
- 210000002593 Y chromosome Anatomy 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 238000012151 immunohistochemical method Methods 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 238000001262 western blot Methods 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000002798 bone marrow cell Anatomy 0.000 description 5
- 238000000684 flow cytometry Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 210000000813 small intestine Anatomy 0.000 description 5
- 210000004989 spleen cell Anatomy 0.000 description 5
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 4
- 206010018691 Granuloma Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 210000001789 adipocyte Anatomy 0.000 description 4
- 230000033115 angiogenesis Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000002308 calcification Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
- 230000011132 hemopoiesis Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 3
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 3
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 3
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 3
- 238000010240 RT-PCR analysis Methods 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 238000012364 cultivation method Methods 0.000 description 3
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
- 229960003957 dexamethasone Drugs 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003725 endotheliocyte Anatomy 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 3
- 238000003119 immunoblot Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 2
- 102100022749 Aminopeptidase N Human genes 0.000 description 2
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 2
- 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 description 2
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 2
- 102000003729 Neprilysin Human genes 0.000 description 2
- 108090000028 Neprilysin Proteins 0.000 description 2
- 108090000573 Osteocalcin Proteins 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 210000004504 adult stem cell Anatomy 0.000 description 2
- 210000003995 blood forming stem cell Anatomy 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 229910052792 caesium Inorganic materials 0.000 description 2
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 239000002458 cell surface marker Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 230000000763 evoking effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 210000003677 hemocyte Anatomy 0.000 description 2
- 229940000351 hemocyte Drugs 0.000 description 2
- 238000002991 immunohistochemical analysis Methods 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000004072 osteoblast differentiation Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- -1 CD31 Proteins 0.000 description 1
- 101100275473 Caenorhabditis elegans ctc-3 gene Proteins 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 230000035519 G0 Phase Effects 0.000 description 1
- 230000010190 G1 phase Effects 0.000 description 1
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 description 1
- 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 description 1
- 101150088608 Kdr gene Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- PKVZBNCYEICAQP-UHFFFAOYSA-N Mecamylamine hydrochloride Chemical compound Cl.C1CC2C(C)(C)C(NC)(C)C1C2 PKVZBNCYEICAQP-UHFFFAOYSA-N 0.000 description 1
- 101000782194 Mus musculus von Willebrand factor Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 102000008763 Neurofilament Proteins Human genes 0.000 description 1
- 108010088373 Neurofilament Proteins Proteins 0.000 description 1
- 101710089162 Neuroglian Proteins 0.000 description 1
- 102000004067 Osteocalcin Human genes 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 102100027208 T-cell antigen CD7 Human genes 0.000 description 1
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000002791 cfu-m Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000009762 endothelial cell differentiation Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003237 epithelioid cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940011399 escin Drugs 0.000 description 1
- 229930186222 escin Natural products 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000001665 muscle stem cell Anatomy 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000009168 stem cell therapy Methods 0.000 description 1
- 238000009580 stem-cell therapy Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
抗人抗体 | 阳性鼠数量/小鼠总数 | 阳性百分率(%) |
CD34 | 7/10 | 1.6(0.9-3.8) |
CD45 | 7/10 | 18.4(1.3-40) |
CD2 | ND | 0 |
CD7 | ND | 0 |
CD10 | 6/10 | 12.7(4.7-32) |
CD13 | 6/10 | 2.9(1.8-4.6) |
CD14 | 6/10 | 2.8(1.4-9.7) |
CD19 | 7/10 | 6.8(4.6-18.4) |
CD33 | 7/10 | 5.2(2.7-17.3) |
CD38 | 5/10 | 17.3(2.4-36.9) |
pan-CK气管 | 5/10 | NC |
SP-B肺 | 6/10 | NC |
pan-CK胃 | 7/10 | NC |
pan-CK肠 | 8/10 | NC |
ALB肝 | 5/10 | NC |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200410084407A CN1778905B (zh) | 2004-11-22 | 2004-11-22 | 一种脂肪间充质干细胞的分离培养方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200410084407A CN1778905B (zh) | 2004-11-22 | 2004-11-22 | 一种脂肪间充质干细胞的分离培养方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1778905A true CN1778905A (zh) | 2006-05-31 |
CN1778905B CN1778905B (zh) | 2010-05-05 |
Family
ID=36769360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200410084407A Active CN1778905B (zh) | 2004-11-22 | 2004-11-22 | 一种脂肪间充质干细胞的分离培养方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1778905B (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010124585A1 (en) * | 2009-04-30 | 2010-11-04 | Adistem Ltd | Methods and apparatuses for isolating and preparing stem cells |
CN101974486A (zh) * | 2010-11-25 | 2011-02-16 | 王泰华 | 从微量人脂肪组织提取间充质干细胞及规模化培养的方法 |
CN101984049A (zh) * | 2010-12-09 | 2011-03-09 | 协和干细胞基因工程有限公司 | 从脂肪组织中分离间充质干细胞的方法 |
CN101215547B (zh) * | 2008-01-15 | 2011-06-08 | 刘岱良 | 一种分离、纯化及提取脂肪间充质干细胞的方法 |
CN102329773A (zh) * | 2011-10-14 | 2012-01-25 | 成都清科生物科技有限公司 | 从膨胀液中分离脂肪间充质干细胞的方法 |
CN102433299A (zh) * | 2011-11-17 | 2012-05-02 | 安徽农业大学 | 小鼠脂肪干细胞的分离、培养及纯化方法 |
WO2012075912A1 (zh) * | 2010-12-09 | 2012-06-14 | 中国医学科学院基础医学研究所 | 亚全能干细胞产品及其表观遗传修饰标签 |
CN102936580A (zh) * | 2012-11-13 | 2013-02-20 | 山东省农业科学院畜牧兽医研究所 | 一种脂肪细胞体外培养方法 |
CN103215222A (zh) * | 2013-04-19 | 2013-07-24 | 陈云燕 | 一种将人脂肪间充质干细胞诱导成神经细胞的诱导培养基及方法 |
CN103459592A (zh) * | 2010-12-09 | 2013-12-18 | 银丰生物工程技术有限公司 | 亚全能干细胞产品及其表观遗传修饰标签 |
CN103540564A (zh) * | 2013-10-21 | 2014-01-29 | 南京优而生物科技发展有限公司 | 自体脂肪间充质干细胞的提取方法 |
CN106350483A (zh) * | 2016-10-14 | 2017-01-25 | 中卫华医(北京)生物科技有限公司 | 诱导脂肪间充质干细胞向软骨细胞分化的培养方法 |
CN106554941A (zh) * | 2016-12-01 | 2017-04-05 | 济南万泉生物技术有限公司 | 一种治疗脱发的脂肪间充质干细胞 |
CN107050517A (zh) * | 2017-05-04 | 2017-08-18 | 宁夏医科大学 | 无外源支架血管化组织工程骨及其制备方法 |
CN111733128A (zh) * | 2020-05-14 | 2020-10-02 | 厚朴生物科技(苏州)有限公司 | 人脂肪间充质干细胞制备方法及体外分化能力鉴定方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1434119A (zh) * | 2001-09-19 | 2003-08-06 | 中国医学科学院中国协和医科大学血液学研究所 | 间充质干细胞表型的成体干细胞重建造血方法的建立及应用 |
-
2004
- 2004-11-22 CN CN200410084407A patent/CN1778905B/zh active Active
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101215547B (zh) * | 2008-01-15 | 2011-06-08 | 刘岱良 | 一种分离、纯化及提取脂肪间充质干细胞的方法 |
WO2010124585A1 (en) * | 2009-04-30 | 2010-11-04 | Adistem Ltd | Methods and apparatuses for isolating and preparing stem cells |
CN101974486A (zh) * | 2010-11-25 | 2011-02-16 | 王泰华 | 从微量人脂肪组织提取间充质干细胞及规模化培养的方法 |
WO2012068710A1 (zh) * | 2010-11-25 | 2012-05-31 | Wang Taihua | 从微量人脂肪组织提取间充质干细胞及规模化培养的方法 |
CN103459592A (zh) * | 2010-12-09 | 2013-12-18 | 银丰生物工程技术有限公司 | 亚全能干细胞产品及其表观遗传修饰标签 |
CN101984049A (zh) * | 2010-12-09 | 2011-03-09 | 协和干细胞基因工程有限公司 | 从脂肪组织中分离间充质干细胞的方法 |
WO2012075912A1 (zh) * | 2010-12-09 | 2012-06-14 | 中国医学科学院基础医学研究所 | 亚全能干细胞产品及其表观遗传修饰标签 |
CN101984049B (zh) * | 2010-12-09 | 2012-11-21 | 协和干细胞基因工程有限公司 | 从脂肪组织中分离间充质干细胞的方法 |
CN103459592B (zh) * | 2010-12-09 | 2016-05-25 | 诺未科技(北京)有限公司 | 亚全能干细胞产品及其表观遗传修饰标签 |
CN102329773A (zh) * | 2011-10-14 | 2012-01-25 | 成都清科生物科技有限公司 | 从膨胀液中分离脂肪间充质干细胞的方法 |
CN102433299A (zh) * | 2011-11-17 | 2012-05-02 | 安徽农业大学 | 小鼠脂肪干细胞的分离、培养及纯化方法 |
CN102433299B (zh) * | 2011-11-17 | 2013-01-23 | 安徽农业大学 | 小鼠脂肪干细胞的分离、培养及纯化方法 |
CN102936580A (zh) * | 2012-11-13 | 2013-02-20 | 山东省农业科学院畜牧兽医研究所 | 一种脂肪细胞体外培养方法 |
CN102936580B (zh) * | 2012-11-13 | 2014-03-26 | 山东省农业科学院畜牧兽医研究所 | 一种脂肪细胞体外培养方法 |
CN103215222A (zh) * | 2013-04-19 | 2013-07-24 | 陈云燕 | 一种将人脂肪间充质干细胞诱导成神经细胞的诱导培养基及方法 |
CN103540564A (zh) * | 2013-10-21 | 2014-01-29 | 南京优而生物科技发展有限公司 | 自体脂肪间充质干细胞的提取方法 |
CN106350483A (zh) * | 2016-10-14 | 2017-01-25 | 中卫华医(北京)生物科技有限公司 | 诱导脂肪间充质干细胞向软骨细胞分化的培养方法 |
CN106554941A (zh) * | 2016-12-01 | 2017-04-05 | 济南万泉生物技术有限公司 | 一种治疗脱发的脂肪间充质干细胞 |
CN107050517A (zh) * | 2017-05-04 | 2017-08-18 | 宁夏医科大学 | 无外源支架血管化组织工程骨及其制备方法 |
CN107050517B (zh) * | 2017-05-04 | 2020-06-02 | 宁夏医科大学 | 无外源支架血管化组织工程骨及其制备方法 |
CN111733128A (zh) * | 2020-05-14 | 2020-10-02 | 厚朴生物科技(苏州)有限公司 | 人脂肪间充质干细胞制备方法及体外分化能力鉴定方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1778905B (zh) | 2010-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Charbord | Bone marrow mesenchymal stem cells: historical overview and concepts | |
US20080020459A1 (en) | Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom | |
CN102367435B (zh) | 人富血小板血浆的制备及在人间充质干细胞分离培养中的应用 | |
CN104204193A (zh) | 间充质干细胞的培养 | |
CN1860222A (zh) | 用于临床和商业用途的干细胞 | |
CN1778905B (zh) | 一种脂肪间充质干细胞的分离培养方法及其应用 | |
TW200804599A (en) | Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates | |
CN101575590B (zh) | 人脐带间充质干细胞的制备方法 | |
CN110938590B (zh) | 一种间充质干细胞无血清培养基及其用途 | |
CN105647856A (zh) | 促进人脐带间充质干细胞向软骨细胞分化的方法 | |
Lei et al. | Biological character of human adipose-derived adult stem cells and influence of donor age on cell replication in culture | |
JP2007525979A (ja) | 間葉系前駆細胞無血清懸濁培養システム | |
CN101285053A (zh) | 一种动态悬浮条件下共同培养脐血造血干细胞与间充质干细胞的方法 | |
CN107287156A (zh) | 一种脂肪间充质干细胞的分离培养方法及其应用 | |
CN1912109A (zh) | 一种组织工程化脂肪组织的构建方法与应用 | |
Gao et al. | Multilineage potential research on pancreatic mesenchymal stem cells of bovine | |
CN102703380B (zh) | 亚全能干细胞、其制备方法及其用途 | |
CN112300986B (zh) | 无血清培养基制备脂肪间充质干细胞的方法 | |
CN101486992B (zh) | 抑制破骨细胞生成的间充质干细胞及其制备方法与应用 | |
CN1932010A (zh) | 一种分离人脂肪组织中内皮祖细胞的方法 | |
Mahboudi et al. | Comparison between high cell-density culture systems for chondrogenic differentiation and articular cartilage reconstruction of human mesenchymal stem cells: a literature review | |
WO2019104466A1 (en) | Methods of producing populations of mesenchymal stem cells from peripheral blood and uses thereof | |
JP6207299B2 (ja) | 間葉系幹細胞の分離方法 | |
CN1397640A (zh) | 一种干细胞、其制备方法及其用途 | |
CN1821272A (zh) | 抗人骨髓间充质干细胞单克隆抗体zue12及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO CO-ORIENT, INC. Free format text: FORMER OWNER: ZHAO CHUNHUA Effective date: 20150909 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150909 Address after: 266100 Shandong Province, Qingdao city Laoshan District Shiling road name 39 International Exchange Building No. 1 room 2103 Patentee after: Qingdao Olympic bio engineering technology Co., Ltd. Address before: 100080 Room 606, Zhongguancun customs, Zhichun Road 59, Beijing, Haidian District Patentee before: Zhao Chunhua |
|
CP03 | Change of name, title or address |
Address after: Longshan Street Xincheng District building A Jimo Powerise Hengye 266200 city in Shandong city of Qingdao Province Patentee after: Qingdao Olympic source Biological Engineering Technology Group Co Ltd Address before: 266100 Shandong Province, Qingdao city Laoshan District Shiling road name 39 International Exchange Building No. 1 room 2103 Patentee before: Qingdao Olympic bio engineering technology Co., Ltd. |
|
CP03 | Change of name, title or address | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Separating culture and use for fatty mesenchymal dry cell Effective date of registration: 20170710 Granted publication date: 20100505 Pledgee: Qingdao rural commercial bank Limited by Share Ltd North Branch Pledgor: Qingdao Olympic source Biological Engineering Technology Group Co Ltd Registration number: 2017990000615 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190806 Granted publication date: 20100505 Pledgee: Qingdao rural commercial bank Limited by Share Ltd North Branch Pledgor: Qingdao Olympic source Biological Engineering Technology Group Co Ltd Registration number: 2017990000615 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Separating culture and use for fatty mesenchymal dry cell Effective date of registration: 20190806 Granted publication date: 20100505 Pledgee: Qingdao rural commercial bank Limited by Share Ltd North Branch Pledgor: Qingdao Olympic source Biological Engineering Technology Group Co Ltd Registration number: Y2019370010002 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200224 Address after: No. 102, 3 / F, Lishui garden, Dongxiaokou Town, Changping District, Beijing 102200 Patentee after: Zhao Chunhua Address before: Longshan Street Xincheng District building A Jimo Powerise Hengye 266200 city in Shandong city of Qingdao Province Patentee before: Qingdao Olympic source Biological Engineering Technology Group Co Ltd |
|
CI03 | Correction of invention patent | ||
CI03 | Correction of invention patent |
Correction item: Patentee|Address Correct: Qingdao guoaoyuan Bioengineering Technology Group Co., Ltd.| 266200 Building a, Xincheng Hengye, Chuangzhi New District, Longshan street, Jimo City, Qingdao City, Shandong Province False: Zhao Chunhua|102200 102, 3 / F, lishuiyuan, Dongxiaokou Town, Changping District, Beijing Number: 11-02 Volume: 36 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210728 Granted publication date: 20100505 Pledgee: Qingdao rural commercial bank Limited by Share Ltd. North Branch Pledgor: QINGDAO GUOAOYUAN BIOENGINEERING TECHNOLOGY GROUP Co.,Ltd. Registration number: Y2019370010002 |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 266200 No. 168 Ningdong Road, Blue New District, Jimo Economic Development Zone, Qingdao City, Shandong Province Patentee after: Qingdao Hualing Aoyuan Bioengineering Technology Group Co.,Ltd. Address before: 266200 building a, Xincheng Hengye, Chuangzhi new area, Longshan street, Jimo City, Qingdao City, Shandong Province Patentee before: QINGDAO GUOAOYUAN BIOENGINEERING TECHNOLOGY GROUP Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for isolation and culture of adipose mesenchymal stem cells and its application Effective date of registration: 20210907 Granted publication date: 20100505 Pledgee: Qingdao rural commercial bank Limited by Share Ltd. North Branch Pledgor: Qingdao Hualing Aoyuan Bioengineering Technology Group Co.,Ltd. Registration number: Y2021370010087 |